<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201563</article-id><article-id pub-id-type="doi">10.1101/2024.11.28.625855</article-id><article-id pub-id-type="archive">PPR947151</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Bioenergetic signature of Synaptic mitochondria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Faria-Pereira</surname><given-names>Andreia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Morais</surname><given-names>Vanessa A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0346k0491</institution-id><institution>GIMM Gulbenkian Institute for Molecular Medicine</institution></institution-wrap>, <city>Lisbon</city>, <country country="PT">Portugal</country></aff><aff id="A2"><label>2</label>Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal</aff><author-notes><corresp id="CR1"><label>*</label><bold>Corresponding author</bold>: Vanessa A. Morais, <email>vanessa.morais@gimm.pt</email>; <email>vmorais@medicina.ulisboa.pt</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>29</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Synaptic transmission is the most energy-demanding processes in the brain and here we show that mitochondria have developed specific properties to efficiently support neurotransmission. It is a known fact that mitochondria at synapses need to be able to deal with a dynamic range of energetic needs overtime and to adapt between resting and high stimulation conditions. However, how mitochondria are adjusting to this requirement was not yet clear. Here, we show that synaptic mitochondria have a distinct bioenergetic profile presenting a stronger ability to respond to respiratory stimulus. These features are explained by a dichotomic Complex I activity pattern where synaptic mitochondria present a decreased enzymatic activity of individual Complex I, yet mitochondria at synapse present a dramatically enhanced Complex I+III combined activity. These bioenergetics features may endow synaptic mitochondria with the necessary mechanisms to adapt to the flexible bioenergetic environment present at synapses.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Neurons are high energy demanding cells with a unique morphological polarization. As ATP has a low diffusion rate<sup><xref ref-type="bibr" rid="R1">1</xref></sup>, neuronal energetic demands need to be met <italic>in loco</italic> for each neuronal sub-compartment. Synaptic transmission is one of the most energy-demanding processes in neurons<sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>, and oxygen consumption promptly increases in response to stimulation<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref></sup>. These synaptic energetic requirements are mainly fulfilled by mitochondrial oxidative phosphorylation which under sustained synaptic activity is complemented by glycolysis<sup><xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup>. Due to the unique intracellular environment, one could postulate that mitochondria at synapses may have an “adapted” profile in comparison to mitochondria that reside in other parts of the neuron or brain. In line with this, lipidomic<sup><xref ref-type="bibr" rid="R13">13</xref></sup> and proteomics<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup> studies show differences in the composition of synaptic mitochondria. Additionally, synaptic mitochondria have a distinct volume, size and ultrastructure compared to mitochondria elsewhere in the neuron and brain (non-synaptic mitochondria)<sup><xref ref-type="bibr" rid="R16">16</xref>–<xref ref-type="bibr" rid="R19">19</xref></sup>. Recent studies show that synaptic stimulation impacts mitochondrial dynamics and biogenesis, either through the recruitment of axonal mitochondria to synapses<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, or through the approximately one-fourth increased synthesis of mitochondrial related proteins at synapses<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. Additionally, these protein translation processes at post-synaptic sites appear to be fuelled by mitochondria<sup><xref ref-type="bibr" rid="R22">22</xref></sup>, emphasizing the interdependence between mitochondria function and sustained synaptic activity.</p><p id="P3">In 1989, Lai and Clark proposed that mitochondria in the brain have some degree of “microheterogeneity”<sup><xref ref-type="bibr" rid="R23">23</xref></sup>, however, were unable to clarify this heterogeneity at the molecular level. Here, we unveil bioenergetic adaptations of mitochondria at the synapse to meet their energetic requirements. Our results show that under resting conditions mitochondria have tailor-made “energetic machinery” on-hold to help responding to the higher energetic demands upon synaptic stimulation.</p></sec><sec id="S2" sec-type="results | discussion"><title>Results and Discussion</title><sec id="S3"><title>Isolation and morphological assessment of synaptic mitochondria</title><p id="P4">Synaptic and non-synaptic mitochondria were isolated from 8-week old mice through differential centrifugation steps (<xref ref-type="fig" rid="F1">Figure 1a</xref>).</p><p id="P5">Transmission electron microscopy (TEM) was used to assess the overall mitochondrial morphology (<xref ref-type="fig" rid="F1">Fig. 1b-d</xref>; <xref ref-type="fig" rid="F7">Extended Data Fig. 1b</xref>). In the untreated synaptosomal fraction (<xref ref-type="fig" rid="F1">Fig. 1b</xref>; <xref ref-type="fig" rid="F7">Extended Data Fig. 1b</xref>), we observe mitochondria (M), synaptic vesicles (SV) and post-synaptic densities (black arrow). Interestingly, several synaptosomes had one or more mitochondria, supporting the enrichment of synaptic mitochondria in these structures<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup>. No significant differences were observed between synaptic (S) and non-synaptic (NS) mitochondria (<xref ref-type="fig" rid="F1">Fig. 1e,f</xref>), challenging previously established ideas that synaptic mitochondria are smaller and rounder than non-synaptic mitochondria<sup><xref ref-type="bibr" rid="R17">17</xref></sup>. Synaptic mitochondria presented increased heterogeneity for area (0.25 ±0.020 for NS vs 0.31±0.034 for S; mean±SEM) and perimeter (1.90±0.079 for NS vs 2.03±0.109; mean±SEM).</p><p id="P6">Expression of mitochondrial protein HSP60 and pre- and post-synaptic markers Synaptophysin1 and PSD95, respectively, were assessed in the different fractions (<xref ref-type="fig" rid="F1">Fig. 1g-j</xref>). As expected, the mitochondrial marker HSP60 was enriched in non-synaptic and synaptic mitochondria in comparison to the brain homogenate (<xref ref-type="fig" rid="F1">Fig. 1g,j</xref>). The synaptic markers, PSD95 and Synaptophysin1 were close to absent in non-synaptic mitochondria, whereas they were detected in synaptic mitochondria, validating the enrichment of each mitochondrial fraction (<xref ref-type="fig" rid="F1">Fig. 1g-i</xref>). The astrocyte marker GFAP, was not enriched in the mitochondrial fractions further validating the enrichments (<xref ref-type="fig" rid="F7">Extended Data Fig. 1a</xref>).</p><p id="P7">To demonstrate that digitonin treatment applied on the synaptosomal fraction maintained the mitochondria membrane integrity<sup><xref ref-type="bibr" rid="R25">25</xref></sup>, lysed synaptosomal fraction were collected (hereafter, synaptosomal membrane) and probed for Citrate Synthase (CS), a mitochondrial matrix protein, VDAC1 and Mitofusin1 (MFN1), both outer mitochondrial membrane proteins, and SNAP25, a non-vesicular synaptosomal protein (<xref ref-type="fig" rid="F7">Extended Data Fig. 1c-f</xref>). CS, VDAC1 and MFN1 are significantly enriched in synaptic mitochondria but not in synaptosomal membrane fractions, whereas SNAP25 is present in both, but increased in synaptosomal membranes. These results indicate that, at this concentration of digitonin, we obtained an enriched fraction of morphological intact synaptic mitochondria.</p><p id="P8">To elucidate the unique properties of mitochondria that reside at the synapse in comparison to non-synaptic mitochondria, a bioenergetic and biochemical profile was established from both fractions.</p></sec><sec id="S4"><title>Synaptic mitochondria present higher bioenergetic flexibility</title><p id="P9">The bioenergetics profile of synaptic and non-synaptic mitochondria was assessed by tracing the oxygen consumption rate (OCR)<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Basal respiration shows that both preparations are metabolically active with non-synaptic mitochondria respiring more than synaptic mitochondria (1206 ± 56,4 pmol/min versus 728,3 ± 37,7 pmol/min, <italic>P</italic>&lt;0,0001) (<xref ref-type="fig" rid="F2">Fig. 2a-b</xref>). To guarantee that ADP was not rate limiting and to boost coupled respirations<sup><xref ref-type="bibr" rid="R26">26</xref></sup>, we applied this substrate in the measurements. The resulting increase in respiration was significantly higher in synaptic mitochondria compared to non-synaptic mitochondria (64,6% ± 4,9% versus 32,9% ± 4,4%, <italic>P</italic>&lt;0,0001) (<xref ref-type="fig" rid="F2">Fig. 2d,e</xref>). When complex V is blocked with oligomycin, the effect was higher in synaptic mitochondria (51,1% ± 1,1% versus 31,1% ± 3,5%, <italic>P</italic>&lt;0,0001) (<xref ref-type="fig" rid="F2">Fig. 2f</xref>) suggesting higher flexibility of synaptic mitochondria to produce ATP. The increase in maximal uncoupler-stimulated respiration was also significantly higher in synaptic mitochondria than in non-synaptic mitochondria (67,7% ± 5,8% versus 17,0% ± 3,4%, <italic>P</italic>&lt;0,0001) (<xref ref-type="fig" rid="F2">Fig. 2g</xref>). After electron transport chain block with Antimycin A, both the synaptic and non-synaptic mitochondrial OCR became drastically decreased to a similar level indicating that none of the mitochondrial fractions have a significant source of non-mitochondrial respiration (<xref ref-type="fig" rid="F2">Fig. 2c</xref>).</p><p id="P10">Thus, while synaptic mitochondria present a reduced basal respiration, they react at a higher magnitude upon different respiratory stimuli. This supports the hypothesis that mitochondria at synapses are in a “low-oxidative phosphorylation” state in basal synaptic transmission, but upon high-demanding synaptic transmission<sup><xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup> are capable to adapt and contribute to synaptic activity.</p></sec><sec id="S5"><title>Synaptic mitochondria have increased OxPHOS complex activity, except for Complex I</title><p id="P11">We assessed the enzymatic activities of the individual respiratory chain complexes (RCCs) I, II, III, IV and V (<xref ref-type="fig" rid="F3">Fig. 3a-e</xref>), as well as, the combined activity of Complex I+III and Complex II+III (<xref ref-type="fig" rid="F3">Fig. 3f,g</xref>) of synaptic and non-synaptic mitochondria. Interestingly, the activities of Complex IV and, more drastically, of Complex V were increased in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3d,e</xref>). However, Complex I activity (<xref ref-type="fig" rid="F3">Fig. 3a</xref>) was decreased in synaptic mitochondria, while no significant changes for Complex II (<xref ref-type="fig" rid="F3">Fig. 3b</xref>) and Complex III (<xref ref-type="fig" rid="F3">Fig. 3c</xref>) were observed, pointing to a differential activity of the RCCs in synaptic mitochondria<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>. Although no significant change of Complex II+III was observed in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3g</xref>), a significant increase in the enzymatic activity of combined Complex I+III was evident in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3f</xref>).</p><p id="P12">The decrease of individual Complex I activity in synaptic mitochondria was confirmed by in-gel activity assay (<xref ref-type="fig" rid="F3">Fig. 3h</xref>), where DMM treated mitochondria were used (condition that only allows analysis of individual RCCs)<sup><xref ref-type="bibr" rid="R29">29</xref></sup>, whereas Complex IV activity was increased in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3i</xref>). Additionally, expression of a subunit from each mitochondrial RCCs was assessed with antibodies against ATP5A (V), MTCO1 (IV), UQCRCR2 (III), SDHB (II) and NDUFB8 (I). Both Complex IV and I subunits protein levels in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3j,k</xref>).</p><p id="P13">Collectively, these data suggests that synaptic mitochondria have a specific and distinct bioenergetic profile than other brain mitochondria, with a higher activity of Complex IV, V and I+III but decreased enzymatic activity of Complex I.</p></sec><sec id="S6"><title>Differential Complex I levels and function in synaptic mitochondria</title><p id="P14">Mammalian Complex I is the largest mitochondrial respiratory chain complex and contains several redox centers where electrons from NADH are accepted by ubiquinone and NADH is oxidized to NAD<sup>+</sup>. Functionally, Complex I can be divided in 3 modules: N-module, where NADH is oxidized and electrons are accepted to FMN; Q-module, where the ubiquinone Coenzyme Q10 is reduced to deliver electrons to Complex III; P-module, where protons are pumped to the mitochondrial intermembrane space, contributing to the build-up of the mitochondrial membrane potential (<xref ref-type="fig" rid="F4">Fig. 4a</xref>).</p><p id="P15">Complex I is also one of the major producers of mitochondrial reactive oxygen species (ROS)<sup><xref ref-type="bibr" rid="R30">30</xref></sup>.</p><p id="P16">We immunoprecipitated Complex I from synaptic and non-synaptic mitochondria and compared the expression of Complex I subunits from the 3 different modules: NDUFV1, NDUFV2, NDUFS1 and NDUFS6 (N-module subunits); NDUFA10 (Q/P-module interface) and NDUFB8 and NDUFB6 (P-module subunits) (<xref ref-type="fig" rid="F4">Fig. 4b-c</xref>). In the “input” fractions, there is an overall decrease in protein levels of Complex I subunits in the synaptic mitochondria (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). In the “eluted” samples decrease in protein levels was mainly observed for the two core subunits of the N-module, NDUFV1 and NDUFV2 (<xref ref-type="fig" rid="F4">Fig. 4c</xref>, *).</p><p id="P17">To assess whether decreased protein levels was due to protein instability, we next analysed the tertiary conformation of these subunits by assessing cysteine modifications using inverse redox shift assays<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. Mitochondrial samples are first exposed to N-ethylmaleimide (NEM) which binds to accessible cysteine residues and is represented by a lower molecular weight band similar to minimum shift control lane (“min” lane). On the other hand, proteins with inaccessible cysteine will present high molecular weight bands similar to maximum shift control lane (“max” lane). In <xref ref-type="fig" rid="F4">Figure 4d</xref>, lower molecular weight bands were not observed for NDUFV1 in both non-synaptic (NS) and synaptic (S) mitochondria. For the NDUFV2 subunit, intermediate molecular weight bands were observed in both maximum, non-synaptic and synaptic mitochondria. Additionally, no exclusive band was shown in synaptic mitochondria in comparison with non-synaptic mitochondria. As expected, no shift bands were observed between minimum, maximum and steady-state samples for NDUFB6, a protein that lacks cysteine residues. As Complex I inactivation can be derived from irreversible conformational changes of N-module subunits<sup><xref ref-type="bibr" rid="R32">32</xref></sup>, our results indicate that this is not the case in synaptic mitochondria. Commonly, Complex I deficiencies are accompanied by a lower NAD<sup>+</sup>/NADH ratio<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. Assessment of the NAD<sup>+</sup>/NADH ratio in non-synaptic and synaptic mitochondria (<xref ref-type="fig" rid="F4">Fig. 4e</xref>) indicated that synaptic mitochondria have a tendency for lower NAD+/NADH ratio and a significantly decreased NAD+ concentration (<xref ref-type="fig" rid="F4">Fig. 4f</xref>). Additionally, the amount of FMN in intact mitochondria was determined and our data shows that synaptic mitochondria indeed have lower FMN content than non-synaptic mitochondria (<xref ref-type="fig" rid="F4">Fig. 4g</xref>), suggesting that lower Complex I activity (<xref ref-type="fig" rid="F4">Fig. 3a,h</xref>) is accompanied by lower function and expression of N-module subunits.</p><p id="P18">Complex I N-module turnover occurs at a higher rate when compared to other Complex I modules<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>. This turnover depends on the mitochondrial ClpXP protease complex, which recognizes and degrades impaired core N-module proteins<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R35">35</xref></sup>. Upon absence of CLpXP complex, N-module turnover is diminished and leads to the accumulation of inactive CI subunits which interfere with the adequate assembly and activity of Complex I<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. ClpPX consists of a CLPP and a CLPX component. CLPP was not different between NS and S mitochondrial (<xref ref-type="fig" rid="F4">Fig. 4h,i</xref>), however, CLPX protein levels were decreased in synaptic mitochondria (1.85 fold) (<xref ref-type="fig" rid="F4">Fig.4j,k</xref>). These lower levels of CLPX can contribute to a “stalling” mechanism of N-module turnover in synaptic mitochondria. However, these lower levels of CLPX do not seem to lead to an accumulation of N-module subcomplexes (<xref ref-type="fig" rid="F8">Extended Fig. 2a</xref>), as observed in CLPP-deficient mouse hearts<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. NDUFAF2 has been proposed to be an assembly factor that accumulates in pre-assembled Complex I (pre-CI) when N-module incorporation is impaired<sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R37">37</xref></sup>. If pre-CI were to accumulate in synaptic mitochondria, an increased NDUFAF2 expression would be expected. However, synaptic mitochondria fractions showed a decreased NDUFAF2 expression when compared to non-synaptic mitochondria (Extended Data Fig. 4b,c). Interestingly, in NDUFAF2 KO cells, Complex I can be fully assembled but its function seems to be impaired<sup><xref ref-type="bibr" rid="R38">38</xref></sup>.</p><p id="P19">At this point, we were able to unravel a N-module expression and function signature in synaptic mitochondria which could be causing the decreased Complex I enzymatic function in synaptic mitochondria and may constitute a protective mechanism that aims to maintain Complex I-produced ROS reduced under basal synaptic activity, as that it has been observed that, upon synaptic stimulation, NDUFV1 expression is enhanced at synapse<sup><xref ref-type="bibr" rid="R21">21</xref></sup>.</p></sec><sec id="S7"><title>Integration of Complex I in supercomplexes is increased in synaptic mitochondria</title><p id="P20">RCCs can be arranged in closer proximity forming supercomplexes, that overall contribute to a lower electron diffusion distance between complexes <sup><xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup>, leading to an increased ATP production efficiency with lower ROS production<sup><xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup>. Our data reveal reduced individual Complex I activity (<xref ref-type="fig" rid="F3">Fig. 3a</xref>) and increased Complex I+III combined enzymatic activity (<xref ref-type="fig" rid="F3">Fig. 3b</xref>) in synaptic mitochondria. To assess Complex I distribution in individual or supercomplexes, we treated mitochondrial-enriched fractions with digitonin, a weak nonionic detergent that maintains supercomplex formation<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. Synaptic mitochondria present decreased levels of individual Complex I but similar levels of supercomplex integrated-Complex I when compared to non-synaptic mitochondria (<xref ref-type="fig" rid="F5">Fig. 5a-d</xref>). Calculating the ratio of Complex I distribution assessing core subunits of N-module (<xref ref-type="fig" rid="F4">Fig. 4a</xref>), NDUFV1 (<xref ref-type="fig" rid="F5">Fig. 5b,g</xref>) and NDUFV2 (<xref ref-type="fig" rid="F5">Fig. 5c,h</xref>), an accessory subunit of N-module, NDUFS6 (<xref ref-type="fig" rid="F5">Fig. 5a,f</xref>) and a subunit of P-module (<xref ref-type="fig" rid="F4">Fig. 4a</xref>), NDUFB6 (<xref ref-type="fig" rid="F5">Fig. 5d,i</xref>), synaptic mitochondria present increased supercomplex integrated-Complex I. No differences in Complex II expression were observed (<xref ref-type="fig" rid="F5">Fig. 5e</xref>). Second-dimension BN/SDS-PAGE (<xref ref-type="fig" rid="F5">Fig. 5j</xref>) of digitonin-solubilized synaptic and non-synaptic mitochondria, confirmed NDUFV1 subunit in supercomplexes and individual Complex I in non-synaptic mitochondria, while NDUFV1 was only detected in supercomplexes of synaptic mitochondria. The Complex III subunit, UQCRFS1, was present in CIII<sub>2</sub> and supercomplex structures in both mitochondrial populations.</p><p id="P21">In-gel activity assays revealed a reduction in individual Complex I activity in synaptic mitochondria, while supercomplex presented no significant difference between the two mitochondrial pools (<xref ref-type="fig" rid="F5">Fig. 5k</xref>). A similar trend is observed for Complex IV activity (<xref ref-type="fig" rid="F5">Fig. 5l</xref>). These data indicates that, although overall Complex I protein levels and individual activity is decreased in synaptic mitochondria, the existent Complex I seems to be almost totally organized into supercomplexes. This feature is a plausible justification for a higher response capacity to energetic demands, previously observed in synaptic mitochondria (<xref ref-type="fig" rid="F2">Fig. 2d-g</xref>).</p></sec><sec id="S8"><title>Synaptic mitochondria show differential arrangement of Complex V</title><p id="P22">Besides differences in Complex I activity, Complex V presented a higher enzymatic activity in synaptic mitochondria when compared to non-synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3e</xref>).</p><p id="P23">Complex V can be organized as monomers, dimers and oligomers<sup><xref ref-type="bibr" rid="R43">43</xref>–<xref ref-type="bibr" rid="R45">45</xref></sup> and these structures improve overall ATP synthesis capacity<sup><xref ref-type="bibr" rid="R45">45</xref></sup>. To decipher Complex V organization in synaptic mitochondria, BN-PAGE/WB analyses of mitochondria subjected to digitonin/protein ratios of 10:1 and 2:1 (<xref ref-type="fig" rid="F6">Fig. 6a</xref>) were performed. As expected, dimeric and oligomeric forms of Complex V were maintained in lower digitonin/protein (2:1) ratio<sup><xref ref-type="bibr" rid="R46">46</xref></sup>. Synaptic mitochondria present an increased incorporation of Complex V in oligomers than non-synaptic mitochondria (<xref ref-type="fig" rid="F6">Fig. 6a,b</xref>), and a subtle tendency for increased dimeric forms also occurs in synaptic mitochondria (<xref ref-type="fig" rid="F6">Fig. 6a,c</xref>), suggesting that the supramolecular organization of Complex V in dimers and oligomers is favoured in synaptic mitochondria, which corroborate higher enzymatic activity of Complex V in synaptic mitochondria (<xref ref-type="fig" rid="F3">Fig. 3e</xref>).</p><p id="P24">In sum, a preferential Complex I incorporation in supercomplexes and an increase in Complex V oligomeric organization may contribute to the increased bioenergetic flexibility of synaptic mitochondria.</p><p id="P25">Overall, mitochondria need to deal with a wide and dynamic range of metabolic conditions and synaptic mitochondria are a clear example: they have to be able to adapt to resting and high stimulation environments which translate into differential energetic needs overtime. Thorough analysis of synaptic mitochondria has revealed that even though a lower respiration rate is observed in resting conditions, upon stimulation of the respiratory chain a higher energetic flexibility is observed. Interestingly, even though a reduced Complex I enzymatic activity, accompanied by a lower FMN and NAD+ content was observed, synaptic mitochondria present increased Complex I integrated supercomplexes clearly supporting an intrinsic bioenergetic-favourable signature of synaptic mitochondria.</p><p id="P26">Upon intense stimulation conditions, where a maximum energetic output is necessary (mainly through OxPHOS<sup><xref ref-type="bibr" rid="R11">11</xref></sup>), more N-module and full Complex I would be generated to sustain those high energetic demands, which is supported by recent study showing that <italic>ex vivo</italic> glutamatergic stimulation of synaptosomes leads to increased NDUFV1 expression<sup><xref ref-type="bibr" rid="R21">21</xref></sup>. Furthermore, in a Complex I deficiency model, where both individual and supercomplexes-integrated Complex I were reduced, it was demonstrated that the early brain energy deficits were detected in synaptosomes whereas non-synaptic mitochondria remained unaffected<sup><xref ref-type="bibr" rid="R47">47</xref></sup>, supporting a critical role of Complex I in synaptic energy metabolism.</p><p id="P27">The preferential integration of Complex I into supercomplexes was previously detected when comparing neuronal and astrocytic mitochondria<sup><xref ref-type="bibr" rid="R42">42</xref></sup>. Our data not only corroborates these findings but further indicates that this feature may actually be a signature of mitochondria at synapse, supporting the concept that mitochondria inside a cell are functionally distinct from mitochondria from other subcellular compartments – the so called “mitochondrial microheterogeneity”<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup>.</p><p id="P28">As the onset of neurodegenerative disorders is associated with synaptic energy deficits, mitochondrial dysfunction and ultimately synaptic degeneration prior to neuronal loss<sup><xref ref-type="bibr" rid="R49">49</xref>–<xref ref-type="bibr" rid="R51">51</xref></sup>, the definition of the bioenergetics profile of synaptic mitochondria under physiological conditions could set the ground to understand the energy deficits that occur in neurodegenerative disorders, even in early asymptomatic stages.</p></sec></sec><sec id="S9" sec-type="material | methods" specific-use="web-only"><title>Material and Methods</title><sec id="S10"><title>Isolation of mouse brain mitochondria</title><p id="P29">All the animal procedures were approved by the institutional ethics committee - Animal Welfare Body of GIMM (ORBEA-GIMM), and authorized and licensed by DGAV - Direcção Geral de Alimentação e Veterinária, the Portuguese Competent Authority for Animal Health. The study was carried out in compliance with the ARRIVE guidelines<sup><xref ref-type="bibr" rid="R52">52</xref></sup>.Brains were isolated from 8 weeks old C57BL/6J female mice and homogenized with a rotating Teflon 30 ml Potter-Elvehjem (15-20 strokes, 800 rpm) in a cold isolation buffer (IB: 10mM HEPES, 225mM sucrose, 75mM D-Mannitol and 1mM EGTA, pH7.4) followed by centrifugation at 600 xg, 10min, 4°C. Brain homogenate fraction was collected and further centrifuged at 15,000 xg, 10min, 4°C. Pellet (crude mitochondrial fraction) was ressuspended in 15% Percoll and applied on a 40% and 24% Percoll cushion and centrifuged in a fixed rotor at 31,000 xg, 9min, 4°C, with maximum acceleration and slow deceleration. Top white phase (mostly myelin) was removed and synaptosomes (in the interphase 15-24% Percoll) and non-synaptic mitochondria (in the interphase 24%-40% Percoll) were collected. In order to collect the synaptic mitochondria, synaptossomes were incubated with 0,6mg/ml digitonin (adapted from <sup><xref ref-type="bibr" rid="R25">25</xref></sup>). Protein concentration was determined using Pierce™ BCA Protein Assay as described by the manufacturer (Thermo Fisher Scientific, 23225).</p></sec><sec id="S11"><title>Oxygen consumption rate on isolated brain mitochondria</title><p id="P30">Mitochondrial function was evaluated by measuring the oxygen consumption rate (OCR) in the XF24 Extracellular Flux Analyzer (Seahorse Bioscience, Agilent). Freshly collected synaptic and non-synaptic mitochondrial fraction (8μg of total protein concentration) were ressuspended in mitochondrial assay solution (MAS) <sup><xref ref-type="bibr" rid="R26">26</xref></sup> and plated in a 24-well Seahorse plate followed by centrifugation 2,000 xg, 2min, 4°C. Three measurements were collected for basal respiration, followed by two measurements after addition of 2mM ADP, followed by two measurements after addition of 20μM oligomycin, followed by two measurements after addition of 20μM Carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP), followed by two measurements after addition of 20μM antimycin A.</p></sec><sec id="S12"><title>Respiratory complexes enzymatic activity assays</title><p id="P31">For this, 2 to 50μg of protein from synaptic and non-synaptic mitochondria was used. Individual Complex I (NADH:decylubiquinone oxidoreductase, rotenone sensitive, Complex II (succinate: decylubiquinone DCPIP reductase, malonate sensitive), Complex III (decylubiquinol:cytochrome c oxidoreductase, antimycin A sensitive), Complex IV (cytochrome c oxidase), Complex V (ATPase, oligomycin sensitive), Complexes I+III (NADH:cytochrome c oxidoreductase, rotenone and antimycin A sensitive), Complexes II+III (succinate:cytochrome c reductase activity) and citrate synthase enzymatic activity were measured as described <sup><xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref></sup>. Values were plotted according to the ratio between the specific enzymatic activity of each complex activity and normalized to citrate synthase enzymatic activity.</p></sec><sec id="S13"><title>In-gel activity of respiratory chain complexes I and IV</title><p id="P32">250μg of mitochondria were ressuspended in 750mM aminocaproic acid, 50mM Bis-Tris/HCl pH7.0, 20μM PMSF and 1% DDM or Digitonin, incubated on ice for 30min (DDM) or 1h (Digitonin), centrifuged at 100,000 xg for 15min and supernatants were collected and protein concentration was determined. Next, 0.25% Coomassie G-250 ressuspended in 750mM aminocaproic acid was added to 30μg of each mitochondrial fraction, similar to <sup><xref ref-type="bibr" rid="R54">54</xref></sup>.</p></sec><sec id="S14"><title>Immunoprecipitation of Complex I subunits</title><p id="P33">Complex I was immunocaptured from brain mitochondrial enriched fractions as described in <sup><xref ref-type="bibr" rid="R55">55</xref></sup>. Samples were further analyzed by immunoblotting.</p></sec><sec id="S15"><title>Immunoblot and BN-PAGE analysis</title><p id="P34">For immunoblot analysis, proteins were separated by SDS-PAGE and electrophoretically transferred onto 0.2μm nitrocellulose membranes. Incubation with primary antibodies was performed overnight at 4°C using dilutions listed in <xref ref-type="table" rid="T1">Table 1</xref>. The following secondary antibodies were used: Horseradish peroxidase (HRP) conjugated anti-rabbit and antimouse (Bio-Rad) at 1:10,000. Detection was done using the chemiluminescent ECL-Plus detection kit (Amersham) on a digital Amersham Imager 680 (GE Healthcare). Semiquantification of band intensity was determined using Image Lite Studio 5.2 software.</p><p id="P35">Samples for blue-native gel electrophoresis (BN-PAGE) were prepared from brain isolated mitochondria. For the solubilization, 10μg digitonin/μg protein was used. Approximately, 25μg of protein was loaded on a 3–12% Native PAGE Bis-Tris gels (Thermo Fisher Scientific) and stained with 0.1% Coomassie R-250 solution. Proteins were electrophoretically transferred onto 0.45μm PVDF membranesand immunodetection was performed as previously described using commercial antibodies (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec id="S16"><title>NAD/NADH quantification</title><p id="P36">Using the colorimetric NAD/NADH Assay, 250μg freshly isolated brain mitochondrial enriched fractions were processed according to the manufacturer’s instructions (ab65348, Abcam). Absorbance at 450nm was measured during 1 to 5 hours. The concentration of total NADH, and NAD and NADH concentrations were obtained by comparison to a NADH standard curve. The values were plotted as the ratio between the calculated concentration of NAD+ and NADH.</p></sec><sec id="S17"><title>FMN content determination</title><p id="P37">1mg/ml of brain isolated mitochondria were mixed with an equal volume of 15% TCA for 10min on ice, centrifuged at 10,000 x g for 10min 4 °C and neutralized with 4M K<sub>2</sub>HPO<sub>4</sub>. Fluorescence was measured at excitation/emission 450/525nm. First, the fluorescence was recorded at acidic conditions, and then under neutral pH conditions (pH ~ 7.4) obtained by addition of 20μl of 4M K<sub>2</sub>HPO<sub>4</sub>. Freshly prepared FMN standard solutions were used to calibrate the fluorescence signal (adapted from <sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup>).</p></sec><sec id="S18"><title>Inverse Redox shift assay</title><p id="P38">Inverse Redox shift protocol was adapted from 31. Briefly,25μg of isolated mitochondria were used for each sample. For minimum shift and maximum shift sample, mitochondria were washed with PBS. For steady-state samples, mitochondria were washed and incubated with ice-cold 20mM N-ethylmaleimide (NEM) for 10min on ice. Incubated samples were concentrated using a Microcon-10kDa columns (Merck) and NEM-PBS was replaced with PBS. Concentrated proteins were ressuspended in ice-cold 8% TCA and incubated overnight at –20°C. Precipitated proteins were centrifuged for 15min at 20,000 xg, 4°C. Protein pellets were washed with ice-cold 5% TCA and solubilized in 1x Laemmli Sample buffer with 10mM Tris(2-carboxyethyl)phosphine (TCEP) with sonication. Samples were incubated for 15min at 45°C with vigorous agitation and cooled down at room temperature. Minimum shift samples were modified with 15mM NEM and maximum shift and steady-state samples were modified with 15mM mm(PEG)24. All samples were incubated at RT in the dark for 1h. Redox state was analyzed by SDS-PAGE immunoblotting.</p></sec><sec id="S19"><title>Electron microscopy</title><p id="P39">Mitochondrial suspensions were fixed in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer previously pre-warmed at room temperature for 1h followed by three washes in the same buffer. Post-fixation was performed with 1% (aq) osmium tetroxide for 1h on ice. En bloc staining was performed with 1% (aq) uranyl acetate for 30 min Samples were embedded into BEEM® capsules filled with EPOXI resin (Epon 812 from EMS) and baked for 48 hours at 68-70°C. Ultrathin sections (70nm) were obtained and collected into 1% formvar coated slot copper grids and post stained with 2% Uranyl acetate. Sections were examined in a Hitachi H7000 electron Microscope at a voltage of 80 Kv and the images were acquired using a Megaview III mid-mounted camera (Olympus) and post-processed using iTEM platform.</p><p id="P40">For analysis of perimeter and mitochondrial area, TEM images (.tiff format) were manually analysed based on the outer mitochondrial membrane (OMM) using Fiji/ImageJ software. The following inclusion criteria were applied: the entire mitochondrial 2D representation had to be within the image, not cutted in the limits and the OMM had to be clearly throughout the mitochondria. Note that in synaptic mitochondria’s TEM images the abundance of mitochondria seems to be lower than in non-synaptic mitochondria’s TEM images; however the samples of each fraction processed for TEM had not the same protein concentration and volume.</p></sec><sec id="S20"><title>Statistical analysis</title><p id="P41">Statistical analysis was performed using GraphPad Prism8.0 (GraphPad Software, Inc.). Each set of data values were subjected to normality tests (Shapiro-Wilk test and Kolmogorov-Smirnov test and assessment of Q-Q plots). When data groups assumed a gaussian (normal) distribution, parametric tests were applied, otherwise non-parametric tests were used. Statistical details of experiments, including the statistical tests used and the number of biological replicates (n), are noted in figure legends. Data are presented as mean ± SEM. Differences were considered significant if p-value was lower than 0.05.</p></sec></sec><sec sec-type="extended-data" id="S21"><title>Extended Data</title><fig id="F7" position="anchor"><label>Extended Data Fig. 1</label><caption><p id="P42"><bold>a</bold>, GFAP expression (<bold>a</bold>), an astrocytic marker in the fractions from brain isolation protocol (<xref ref-type="fig" rid="F1">Fig. 1a</xref>) (n=2). TEM images of freshly isolated untreated synaptossomes; non-synaptic and synaptic mitochondria (related to <xref ref-type="fig" rid="F1">Fig. 1</xref>); synaptic vesicles (SV), mitochondria (M) and post-synaptic density (black arrow). Scale bar = 500 nm. Expression (<bold>c</bold>) of SNAP25, a synaptosomal marker not membrane-associated and mitochondrial protein markers: Citrate Synthase (CS) (<bold>c</bold>, <bold>d</bold>), a mitochondrial matrix protein, Mitofusin1 (MFN1) (<bold>c</bold>, <bold>e</bold>) and VDAC1 (<bold>c</bold>, <bold>f</bold>), both outer mitochondrial membrane proteins in the fractions from brain isolation protocol (<xref ref-type="fig" rid="F1">Fig. 1a</xref>) (n=4). <bold>d</bold>, <bold>e</bold> and <bold>f</bold> show means ± S.E.M., determined by one-way ANOVA with post-hoc Tukey test, *<italic>P &lt; 0.05, **P</italic> &lt;0.01, ***<italic>P</italic> &lt; 0.001.</p></caption><graphic xlink:href="EMS201563-f007"/></fig><fig id="F8" position="anchor"><label>Extended Data Fig. 2</label><caption><title>N-module is not stalled in synaptic mitochondria.</title><p id="P43">BN-PAGE (<bold>a</bold>) with DDM-treated mitochondrial fractions of synaptic (S) and non-synaptic (NS) mitochondria and probed for NDUFV1, NDUFV2 and NDUFB6 (n=2-3). Protein expression (<bold>b</bold>) and quantification (<bold>c</bold>) of NDUFAF2 expression in synaptic (S) and non-synaptic (NS) mitochondria. Bands intensity were normalized for Mitofusin1 (MFN1) expression. <bold>c</bold> show means ± S.E.M., determined by two-tailed paired t-test, *<italic>P&lt; 0.05</italic> (n=9).</p></caption><graphic xlink:href="EMS201563-f008"/></fig></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Extended Data</label><media xlink:href="EMS201563-supplement-Extended_Data.pdf" mimetype="application" mime-subtype="pdf" id="d92aAcEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements</title><p>The authors are grateful to all VMorais lab members for their input and technical assistance, especially to Carlos Cardanho-Ramos and Bernardo Antunes. The authors are grateful to the Animal and Comparative Pathology (especially Tânia Carvalho and Andreia Pinto) facilities, and we also acknowledge the funding PPBI-POCI-01-3700145-FEDER-022122. The authors are also thankful to LLopes and EGomes labs at GIMM for their help in provision of antibodies and animals.</p><sec id="S23"><title>Funding</title><p>This project was supported by European Molecular Biology Organization (EMBO-IG/3309); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 679168); and Fundação para a Ciência e a Tecnologia (FCT) (PTDC/BIA-CEL/31230/2017; PTDC/MED/-NEU/7976/2020); Ministério da Ciência, Tecnologia e Ensino Superior (MCTES) through Fundos do Orçamento de Estado (FPJ 1081 Financiamento Estratégico 2019; UID/BIM/50005/2019).</p><p>A.F.-P. was a holder of fellowships (PD/BD/114113/2015; IMM/BI/76-2019) and V.A.M. was an iFCT researcher (IF/01693/2014; IMM/CT/27-2020; 2021.03613.CEECIND).</p></sec></ack><fn-group><fn id="FN1" fn-type="con"><p id="P44"><bold>Author contributions</bold></p><p id="P45">Conceptualization – A.F.-P.; V.A.M; Methodology – A.F.-P.; K. C.; Investigation – A.F.- P.; Formal analysis: A.F.-P.; Data curation – A.F.-P.; Writing – A.F.-P.; V.A.M.; Supervision – V.A.M.; Funding acquisition – V.A.M.</p></fn><fn id="FN2" fn-type="conflict"><p id="P46"><bold>Competing Interests Statement</bold></p><p id="P47"><bold>Nothing to declare</bold></p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubley</surname><given-names>MJ</given-names></name><name><surname>Rosanske</surname><given-names>RC</given-names></name><name><surname>Moerland</surname><given-names>TS</given-names></name></person-group><article-title>Diffusion coefficients of ATP and creatine phosphate in isolated muscle: pulsed gradient 31P NMR of small biological samples</article-title><source>NMR Biomed</source><year>1995</year><volume>8</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">7547189</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Laughlin</surname><given-names>SB</given-names></name></person-group><article-title>An energy budget for signaling in the grey matter of the brain</article-title><source>J Cereb blood flow Metab Off J Int Soc Cereb Blood Flow Metab</source><year>2001</year><volume>21</volume><fpage>1133</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">11598490</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>M</given-names></name><name><surname>Lauwers</surname><given-names>E</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><article-title>Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease</article-title><source>Front Synaptic Neurosci</source><year>2010</year><volume>2</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmcid">PMC3059669</pub-id><pub-id pub-id-type="pmid">21423525</pub-id><pub-id pub-id-type="doi">10.3389/fnsyn.2010.00139</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V</given-names></name><name><surname>Calloway</surname><given-names>N</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><article-title>Activity-driven local ATP synthesis is required for synaptic function</article-title><source>Cell</source><year>2014</year><volume>156</volume><fpage>825</fpage><lpage>835</lpage><pub-id pub-id-type="pmcid">PMC3955179</pub-id><pub-id pub-id-type="pmid">24529383</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2013.12.042</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>D</given-names></name><etal/></person-group><article-title>The role of mitochondrially derived ATP in synaptic vesicle recycling</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>22325</fpage><lpage>22336</lpage><pub-id pub-id-type="pmcid">PMC4566209</pub-id><pub-id pub-id-type="pmid">26126824</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M115.656405</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>CN</given-names></name><name><surname>Klein-Flugge</surname><given-names>MC</given-names></name><name><surname>Howarth</surname><given-names>C</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><article-title>Oxidative Phosphorylation, Not Glycolysis, Powers Presynaptic and Postsynaptic Mechanisms Underlying Brain Information Processing</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>8940</fpage><lpage>8951</lpage><pub-id pub-id-type="pmcid">PMC3390246</pub-id><pub-id pub-id-type="pmid">22745494</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0026-12.2012</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>AI</given-names></name><etal/></person-group><article-title>Glycolysis and oxidative phosphorylation in neurons and astrocytes during network activity in hippocampal slices</article-title><source>J Cereb blood flow Metab Off J Int Soc Cereb Blood Flow Metab</source><year>2014</year><volume>34</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="pmcid">PMC3948126</pub-id><pub-id pub-id-type="pmid">24326389</pub-id><pub-id pub-id-type="doi">10.1038/jcbfm.2013.222</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lujan</surname><given-names>B</given-names></name><name><surname>Kushmerick</surname><given-names>C</given-names></name><name><surname>Das Banerjee</surname><given-names>T</given-names></name><name><surname>Dagda</surname><given-names>RK</given-names></name><name><surname>Renden</surname><given-names>R</given-names></name></person-group><article-title>Glycolysis selectively shapes the presynaptic action potential waveform</article-title><source>J Neurophysiol</source><year>2016</year><volume>116</volume><fpage>2523</fpage><lpage>2540</lpage><pub-id pub-id-type="pmcid">PMC5133309</pub-id><pub-id pub-id-type="pmid">27605535</pub-id><pub-id pub-id-type="doi">10.1152/jn.00629.2016</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function Article Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function</article-title><year>2016</year><fpage>278</fpage><lpage>291</lpage><pub-id pub-id-type="pmcid">PMC4840048</pub-id><pub-id pub-id-type="pmid">27068791</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.011</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Farrell</surname><given-names>RJ</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><article-title>GLUT4 Mobilization Supports Energetic Demands of Active Synapses</article-title><source>Neuron</source><year>2017</year><volume>93</volume><fpage>606</fpage><lpage>615</lpage><elocation-id>e3</elocation-id><pub-id pub-id-type="pmcid">PMC5330257</pub-id><pub-id pub-id-type="pmid">28111082</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.020</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobieski</surname><given-names>C</given-names></name><name><surname>Fitzpatrick</surname><given-names>MJ</given-names></name><name><surname>Mennerick</surname><given-names>SJ</given-names></name></person-group><article-title>Differential Presynaptic ATP Supply for Basal and High-Demand Transmission</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><fpage>1888</fpage><lpage>1899</lpage><pub-id pub-id-type="pmcid">PMC5320616</pub-id><pub-id pub-id-type="pmid">28093477</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2712-16.2017</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Díaz-García</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake</article-title><source>Cell Metab</source><year>2017</year><volume>26</volume><fpage>361</fpage><lpage>374</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="pmcid">PMC5559896</pub-id><pub-id pub-id-type="pmid">28768175</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2017.06.021</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiebish</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria</article-title><source>J Neurochem</source><year>2008</year><volume>106</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="pmcid">PMC3104050</pub-id><pub-id pub-id-type="pmid">18373617</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05383.x</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stauch</surname><given-names>KL</given-names></name><name><surname>Purnell</surname><given-names>PR</given-names></name><name><surname>Fox</surname><given-names>HS</given-names></name></person-group><article-title>Quantitative proteomics of synaptic and nonsynaptic mitochondria: insights for synaptic mitochondrial vulnerability</article-title><source>J Proteome Res</source><year>2014</year><volume>13</volume><fpage>2620</fpage><lpage>2636</lpage><pub-id pub-id-type="pmcid">PMC4015687</pub-id><pub-id pub-id-type="pmid">24708184</pub-id><pub-id pub-id-type="doi">10.1021/pr500295n</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Völgyi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Synaptic mitochondria: a brain mitochondria cluster with a specific proteome</article-title><source>J Proteomics</source><year>2015</year><volume>120</volume><fpage>142</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">25782751</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavan</surname><given-names>V</given-names></name><etal/></person-group><article-title>Central Presynaptic Terminals Are Enriched in ATP but the Majority Lack Mitochondria</article-title><year>2015</year><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmcid">PMC4416033</pub-id><pub-id pub-id-type="pmid">25928229</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125185</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>HL</given-names></name><etal/></person-group><article-title>Mitochondrial support of persistent presynaptic vesicle mobilization with age-dependent synaptic growth after LTP</article-title><source>Elife</source><year>2016</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC5235352</pub-id><pub-id pub-id-type="pmid">27991850</pub-id><pub-id pub-id-type="doi">10.7554/eLife.15275</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cserép</surname><given-names>C</given-names></name><name><surname>Pósfai</surname><given-names>B</given-names></name><name><surname>Schwarcz</surname><given-names>AD</given-names></name><name><surname>Dénes</surname><given-names>Á</given-names></name></person-group><article-title>Mitochondrial Ultrastructure Is Coupled to Synaptic Performance at Axonal Release Sites</article-title><source>eNeuro</source><year>2018</year><volume>5</volume><elocation-id>ENEURO.0390-17.2018</elocation-id><pub-id pub-id-type="pmcid">PMC5788698</pub-id><pub-id pub-id-type="pmid">29383328</pub-id><pub-id pub-id-type="doi">10.1523/ENEURO.0390-17.2018</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>RM</given-names></name><name><surname>Johnson</surname><given-names>JD</given-names></name><name><surname>Ashby</surname><given-names>MC</given-names></name></person-group><article-title>Presynaptic Boutons That Contain Mitochondria Are More Stable</article-title><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6966497</pub-id><pub-id pub-id-type="pmid">31998110</pub-id><pub-id pub-id-type="doi">10.3389/fnsyn.2019.00037</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Xiong</surname><given-names>G-J</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Sheng</surname><given-names>Z-H</given-names></name></person-group><article-title>The cross-talk of energy sensing and mitochondrial anchoring sustains synaptic efficacy by maintaining presynaptic metabolism</article-title><source>Nat Metab</source><year>2020</year><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmcid">PMC7572785</pub-id><pub-id pub-id-type="pmid">33020662</pub-id><pub-id pub-id-type="doi">10.1038/s42255-020-00289-0</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzniewska</surname><given-names>B</given-names></name><etal/></person-group><article-title>Mitochondrial protein biogenesis in the synapse is supported by local translation</article-title><source>EMBO Rep</source><year>2020</year><volume>21</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC7403725</pub-id><pub-id pub-id-type="pmid">32558077</pub-id><pub-id pub-id-type="doi">10.15252/embr.201948882</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>V</given-names></name><name><surname>Lauterbach</surname><given-names>M</given-names></name><name><surname>Schuman</surname><given-names>EM</given-names></name></person-group><article-title>Spatially Stable Mitochondrial Compartments Fuel Local Translation during Plasticity</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>73</fpage><lpage>84</lpage><elocation-id>e15</elocation-id><pub-id pub-id-type="pmid">30612742</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>JCK</given-names></name><name><surname>Clark</surname><given-names>JB</given-names></name></person-group><chapter-title>Isolation and Characterization of Synaptic and Nonsynaptic Mitochondria from Mammalian Brain</chapter-title><person-group person-group-type="editor"><name><surname>Boulton</surname><given-names>AA</given-names></name><name><surname>Baker</surname><given-names>GB</given-names></name><name><surname>Butterworth</surname><given-names>RF</given-names></name></person-group><source>Carbohydrates and Energy Metabolism</source><publisher-name>Humana Press</publisher-name><year>1989</year><fpage>43</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1385/0-89603-143-8:43</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>RF</given-names></name><name><surname>G</surname><given-names>A</given-names></name><name><surname>Lo</surname><given-names>A</given-names></name><name><surname>Orbo</surname><given-names>CD</given-names></name></person-group><article-title>A Critique on the Preparation and Enzymatic Characterization of Synaptic and Nonsynaptic Mitochondria from Hippocampus</article-title><year>1989</year><volume>9</volume><fpage>247</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">2743381</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristian</surname><given-names>T</given-names></name></person-group><article-title>Isolation of mitochondria from the CNS</article-title><source>Curr Protoc Neurosci</source><year>2010</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC2908900</pub-id><pub-id pub-id-type="pmid">20578034</pub-id><pub-id pub-id-type="doi">10.1002/0471142301.ns0722s52</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>GW</given-names></name><etal/></person-group><article-title>High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><pub-id pub-id-type="pmcid">PMC3143121</pub-id><pub-id pub-id-type="pmid">21799747</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021746</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>SW</given-names></name><name><surname>Norman</surname><given-names>JP</given-names></name><name><surname>Barbieri</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>EB</given-names></name><name><surname>Gelbard</surname><given-names>HA</given-names></name></person-group><article-title>Mitochondrial membrane potential probes and the proton gradient: a practical usage guide</article-title><source>Biotechniques</source><year>2011</year><volume>50</volume><fpage>98</fpage><lpage>115</lpage><pub-id pub-id-type="pmcid">PMC3115691</pub-id><pub-id pub-id-type="pmid">21486251</pub-id><pub-id pub-id-type="doi">10.2144/000113610</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>A</given-names></name><etal/></person-group><article-title>Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain</article-title><source>Dev Neurosci</source><year>1995</year><volume>17</volume><fpage>212</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">8575340</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acín-Pérez</surname><given-names>R</given-names></name><name><surname>Fernández-Silva</surname><given-names>P</given-names></name><name><surname>Peleato</surname><given-names>ML</given-names></name><name><surname>Pérez-Martos</surname><given-names>A</given-names></name><name><surname>Enriquez</surname><given-names>JA</given-names></name></person-group><article-title>Respiratory active mitochondrial supercomplexes</article-title><source>Mol Cell</source><year>2008</year><volume>32</volume><fpage>529</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">19026783</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirst</surname><given-names>J</given-names></name><name><surname>King</surname><given-names>MS</given-names></name><name><surname>Pryde</surname><given-names>KR</given-names></name></person-group><article-title>The production of reactive oxygen species by complex I</article-title><source>Biochem Soc Trans</source><year>2008</year><volume>36</volume><fpage>976</fpage><lpage>980</lpage><pub-id pub-id-type="pmid">18793173</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczepanowska</surname><given-names>K</given-names></name><etal/></person-group><article-title>A salvage pathway maintains highly functional respiratory complex I</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC7118099</pub-id><pub-id pub-id-type="pmid">32242014</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-15467-7</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurd</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>24801</fpage><lpage>24815</lpage><pub-id pub-id-type="pmcid">PMC2529008</pub-id><pub-id pub-id-type="pmid">18611857</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M803432200</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamanlidis</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure</article-title><source>Cell Metab</source><year>2013</year><volume>18</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="pmcid">PMC3779647</pub-id><pub-id pub-id-type="pmid">23931755</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2013.07.002</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bomba-Warczak</surname><given-names>E</given-names></name><name><surname>Edassery</surname><given-names>SL</given-names></name><name><surname>Hark</surname><given-names>TJ</given-names></name><name><surname>Savas</surname><given-names>JN</given-names></name></person-group><article-title>Long-lived mitochondrial cristae proteins in mouse heart and brain</article-title><source>J Cell Biol</source><year>2021</year><volume>220</volume><pub-id pub-id-type="pmcid">PMC8282663</pub-id><pub-id pub-id-type="pmid">34259807</pub-id><pub-id pub-id-type="doi">10.1083/jcb.202005193</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>F</given-names></name><name><surname>Langer</surname><given-names>JD</given-names></name><name><surname>Osiewacz</surname><given-names>HD</given-names></name></person-group><article-title>Identification of potential mitochondrial CLPXP protease interactors and substrates suggests its central role in energy metabolism</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><elocation-id>18375</elocation-id><pub-id pub-id-type="pmcid">PMC4683621</pub-id><pub-id pub-id-type="pmid">26679294</pub-id><pub-id pub-id-type="doi">10.1038/srep18375</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvaruso</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity</article-title><source>Hum Mol Genet</source><year>2011</year><volume>21</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">21965299</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protasoni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Respiratory supercomplexes act as a platform for complex III-mediated maturation of human mitochondrial complexes I and IV</article-title><source>EMBO J</source><year>2020</year><volume>39</volume><elocation-id>e102817</elocation-id><pub-id pub-id-type="pmcid">PMC6996572</pub-id><pub-id pub-id-type="pmid">31912925</pub-id><pub-id pub-id-type="doi">10.15252/embj.2019102817</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlehe</surname><given-names>JS</given-names></name><name><surname>Journel</surname><given-names>MSM</given-names></name><name><surname>Taylor</surname><given-names>KP</given-names></name><name><surname>Amodeo</surname><given-names>KD</given-names></name><name><surname>LaVoie</surname><given-names>MJ</given-names></name></person-group><article-title>The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress</article-title><source>Neurobiol Dis</source><year>2013</year><volume>58</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="pmcid">PMC3748239</pub-id><pub-id pub-id-type="pmid">23702311</pub-id><pub-id pub-id-type="doi">10.1016/j.nbd.2013.05.007</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuchebrukhov</surname><given-names>A</given-names></name><name><surname>Schäfer</surname><given-names>J</given-names></name><name><surname>Berg</surname><given-names>J</given-names></name><name><surname>Brzezinski</surname><given-names>P</given-names></name></person-group><article-title>Kinetic advantage of forming respiratory supercomplexes</article-title><source>Biochim Biophys acta Bioenerg</source><year>2020</year><volume>1861</volume><elocation-id>148193</elocation-id><pub-id pub-id-type="pmid">32201307</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berndtsson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Respiratory supercomplexes enhance electron transport by decreasing cytochrome c diffusion distance</article-title><source>EMBO Rep</source><year>2020</year><volume>21</volume><elocation-id>e51015</elocation-id><pub-id pub-id-type="pmcid">PMC7726804</pub-id><pub-id pub-id-type="pmid">33016568</pub-id><pub-id pub-id-type="doi">10.15252/embr.202051015</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maranzana</surname><given-names>E</given-names></name><name><surname>Barbero</surname><given-names>G</given-names></name><name><surname>Falasca</surname><given-names>AI</given-names></name><name><surname>Lenaz</surname><given-names>G</given-names></name><name><surname>Genova</surname><given-names>ML</given-names></name></person-group><article-title>Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I</article-title><source>Antioxid Redox Signal</source><year>2013</year><volume>19</volume><fpage>1469</fpage><lpage>1480</lpage><pub-id pub-id-type="pmcid">PMC3797460</pub-id><pub-id pub-id-type="pmid">23581604</pub-id><pub-id pub-id-type="doi">10.1089/ars.2012.4845</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Fabuel</surname><given-names>I</given-names></name><etal/></person-group><article-title>Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes</article-title><source>Proc Natl Acad Sci U S A</source><year>2016</year><volume>113</volume><fpage>13063</fpage><lpage>13068</lpage><pub-id pub-id-type="pmcid">PMC5135366</pub-id><pub-id pub-id-type="pmid">27799543</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1613701113</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>TB</given-names></name><name><surname>Hahn</surname><given-names>A</given-names></name><name><surname>Meier</surname><given-names>T</given-names></name><name><surname>Davies</surname><given-names>KM</given-names></name><name><surname>Kühlbrandt</surname><given-names>W</given-names></name></person-group><article-title>Dimers of mitochondrial ATP synthase induce membrane curvature and self-assemble into rows</article-title><source>Proc Natl Acad Sci</source><year>2019</year><pub-id pub-id-type="pmcid">PMC6410833</pub-id><pub-id pub-id-type="pmid">30760595</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1816556116</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spikes</surname><given-names>TE</given-names></name><name><surname>Montgomery</surname><given-names>MG</given-names></name><name><surname>Walker</surname><given-names>JE</given-names></name></person-group><article-title>Structure of the dimeric ATP synthase from bovine mitochondria</article-title><source>Proc Natl Acad Sci</source><year>2020</year><volume>117</volume><fpage>23519</fpage><lpage>23526</lpage><pub-id pub-id-type="pmcid">PMC7519299</pub-id><pub-id pub-id-type="pmid">32900941</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2013998117</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonckheere</surname><given-names>AI</given-names></name><name><surname>Smeitink</surname><given-names>JAM</given-names></name><name><surname>Rodenburg</surname><given-names>RJT</given-names></name></person-group><article-title>Mitochondrial ATP synthase: architecture, function and pathology</article-title><source>J Inherit Metab Dis</source><year>2012</year><volume>35</volume><fpage>211</fpage><lpage>225</lpage><pub-id pub-id-type="pmcid">PMC3278611</pub-id><pub-id pub-id-type="pmid">21874297</pub-id><pub-id pub-id-type="doi">10.1007/s10545-011-9382-9</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schägger</surname><given-names>H</given-names></name><name><surname>Pfeiffer</surname><given-names>K</given-names></name></person-group><article-title>Supercomplexes in the respiratory chains of yeast and mammalian mitochondria</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>1777</fpage><lpage>1783</lpage><pub-id pub-id-type="pmcid">PMC302020</pub-id><pub-id pub-id-type="pmid">10775262</pub-id><pub-id pub-id-type="doi">10.1093/emboj/19.8.1777</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayser</surname><given-names>EB</given-names></name><name><surname>Sedensky</surname><given-names>MM</given-names></name><name><surname>Morgan</surname><given-names>PG</given-names></name></person-group><article-title>Region-specific defects of respiratory capacities in the Ndufs4(KO) mouse brain</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmcid">PMC4732614</pub-id><pub-id pub-id-type="pmid">26824698</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0148219</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorovich</surname><given-names>SV</given-names></name><name><surname>Waseem</surname><given-names>TV</given-names></name><name><surname>Puchkova</surname><given-names>LV</given-names></name></person-group><article-title>Biogenetic and morphofunctional heterogeneity of mitochondria: the case of synaptic mitochondria</article-title><source>Rev Neurosci</source><year>2017</year><volume>28</volume><fpage>363</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">28195557</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheff</surname><given-names>SW</given-names></name><name><surname>Price</surname><given-names>DA</given-names></name><name><surname>Schmitt</surname><given-names>FA</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name><name><surname>Mufson</surname><given-names>EJ</given-names></name></person-group><article-title>Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>1501</fpage><lpage>1508</lpage><pub-id pub-id-type="pmid">17470753</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H-C</given-names></name><name><surname>Ulane</surname><given-names>CM</given-names></name><name><surname>Burke</surname><given-names>RE</given-names></name></person-group><article-title>Clinical progression in Parkinson disease and the neurobiology of axons</article-title><source>Ann Neurol</source><year>2010</year><volume>67</volume><fpage>715</fpage><lpage>725</lpage><pub-id pub-id-type="pmcid">PMC2918373</pub-id><pub-id pub-id-type="pmid">20517933</pub-id><pub-id pub-id-type="doi">10.1002/ana.21995</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro-Cardoso</surname><given-names>VF</given-names></name><etal/></person-group><article-title>Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer’s disease</article-title><source>J Alzheimers Dis</source><year>2015</year><volume>43</volume><fpage>1375</fpage><lpage>1392</lpage><pub-id pub-id-type="pmid">25182746</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Percie du Sert</surname><given-names>N</given-names></name><etal/></person-group><article-title>The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research</article-title><source>PLOS Biol</source><year>2020</year><volume>18</volume><elocation-id>e3000410</elocation-id><pub-id pub-id-type="pmcid">PMC7360023</pub-id><pub-id pub-id-type="pmid">32663219</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000410</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>A</given-names></name><name><surname>Fontanesi</surname><given-names>F</given-names></name><name><surname>Díaz</surname><given-names>F</given-names></name></person-group><article-title>Evaluation of the mitochondrial respiratory Chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays</article-title><source>Curr Protoc Hum Genet</source><year>2009</year><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmcid">PMC2771113</pub-id><pub-id pub-id-type="pmid">19806590</pub-id><pub-id pub-id-type="doi">10.1002/0471142905.hg1903s63</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Parkinson’s disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function</article-title><source>EMBO Mol Med</source><year>2009</year><volume>1</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="pmcid">PMC3378121</pub-id><pub-id pub-id-type="pmid">20049710</pub-id><pub-id pub-id-type="doi">10.1002/emmm.200900006</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>VA</given-names></name><etal/></person-group><article-title>PINK1 Loss of Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling</article-title><source>Science</source><year>2014</year><elocation-id>science.1249161</elocation-id><pub-id pub-id-type="pmid">24652937</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stepanova</surname><given-names>A</given-names></name><etal/></person-group><article-title>Redox-Dependent Loss of Flavin by Mitochondrial Complex i in Brain Ischemia/Reperfusion Injury</article-title><source>Antioxidants Redox Signal</source><year>2019</year><volume>31</volume><fpage>608</fpage><lpage>622</lpage><pub-id pub-id-type="pmcid">PMC6657304</pub-id><pub-id pub-id-type="pmid">31037949</pub-id><pub-id pub-id-type="doi">10.1089/ars.2018.7693</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Isolation and morphological comparison of mouse synaptic and non-synaptic mitochondria.</title><p><bold>a</bold>, scheme of isolation procedure and representative TEM images of <bold>b</bold>, freshly isolated, undisrupted synaptosomes with synaptic vesicles (SV), mitochondria (M) and post-synaptic density (black arrow); <bold>c</bold>, non-synaptic mitochondria and <bold>d</bold>, synaptic mitochondria. (scale bar = 500 nm). Quantification of mitochondrial area (μm<sup>2</sup>) (<bold>e</bold>) and mitochondrial perimeter (nm) (<bold>f</bold>) from TEM images of non-synaptic and synaptic mitochondria (representative of 4 images per condition, from n=1 biological replicate). Expression (<bold>g</bold>) and quantification of post-synaptic PSD-95 (<bold>h</bold>), pre-synaptic Synaptophysin1 (<bold>i</bold>) and mitochondrial marker HSP60 (<bold>j</bold>) (n= 4 biological replicates). <bold>e</bold>, <bold>f</bold>, <bold>h</bold>, <bold>i</bold> and <bold>j</bold> show means ± S.E.M., determined by two-tailed Mann-Whitney test (<bold>b</bold>), twot-ailed unpaired t-test (<bold>b</bold>) and two-tailed unpaired t-test with Welch’s correction (<bold>h</bold> - <bold>j</bold>), *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="EMS201563-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>Freshly isolated brain mitochondria are bioenergetically active.</title><p><bold>a</bold> and <bold>d</bold>, oxygen consumption rate (OCR) curves and quantification of 8ug non-synaptic and synaptic mitochondria showing basal conditions (<bold>b</bold>) and non-mitochondrial respiration (<bold>c</bold>). Percentage of OCR increase after ADP (<bold>e</bold>) and FCCP (<bold>g</bold>) and OCR decrease after Oligomycin (<bold>f</bold>) (n=6). <bold>a</bold> - <bold>g</bold> show means ± S.E.M., determined by two-tailed unpaired t-test (<bold>b</bold>, <bold>c</bold> and <bold>e</bold>), and two-tailed unpaired t-test with Welch’s correction (<bold>f</bold>, <bold>g</bold>), *<italic>P &lt; 0.05,</italic> ****<italic>P</italic> &lt; 0.0001.</p></caption><graphic xlink:href="EMS201563-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Synaptic mitochondria show different individual and combined activity of the respiratory chain complexes.</title><p>Enzymatic activities of the individual respiratory chain complexes I, II, III, IV and V (<bold>a</bold> - <bold>e</bold>), as well as, combined activity of Complex I+III (<bold>f</bold>) and Complex II+III (<bold>g</bold>) were assessed in synaptic mitochondria and normalized for the respective activity of non-synaptic mitochondria. All activities were normalized to Citrate Synthase (CS) activity (n=6-17). In-gel activity of Complex I in DDM-treated brain mitochondria for Complex I (<bold>h</bold>) and Complex IV enzymatic activity (<bold>i</bold>) in synaptic mitochondria (S) in comparison to non-synaptic mitochondria (NS) (n=4). Protein expression (<bold>j</bold>) and quantification (<bold>k</bold>) of a subunit of each mitochondria RCCs in synaptic (S) and non-synaptic (NS) mitochondria. Bands intensity were normalized for Mitofusin1 (MFN1) expression (n=6). <bold>a-g</bold>, <bold>k</bold> show means ± S.E.M., determined by two-tailed unpaired t-test with Welch’s correction (<bold>a-g</bold>) and two-tailed paired t-test (<bold>k</bold>). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="EMS201563-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>Differential Complex I levels and function in synaptic mitochondria.</title><p>Schematic (<bold>a</bold>) of Complex I structural composition: N-module (green), where NADH is oxidized to NAD<sup>+</sup> and flavin mononucleotide (FMN) is bound; Q-module (blue), where electrons are transfered to ubiquinone; P-module (orange) localised in the mitochondrial inner membrane and where protons (H<sup>+</sup>) and pumped to the mitochondrial inner membrane space. Coomassie blue staining (<bold>b</bold>) and immunoblot (<bold>c</bold>) of subunits from different modules of Complex I in co-immunoprecipitation fractions from synaptic (S) and non-synaptic (NS) mitochondria (n=2). (<bold>d</bold>) Inverse Redox shift assay followed by immunoblot of NDUFV1, NDUFV2 and NDUFB6 in synaptic (S) and non-synaptic (NS) mitochondrial fractions (n=4). NAD/NADH ratio (n=2) (<bold>e</bold>), NAD+ quantification (n=4) (<bold>f</bold>) and FMN content determination (n=8) (<bold>g</bold>) of synaptic and non-synaptic mitochondrial-enriched fractions. CLPP expression (<bold>h</bold>) and quantification (<bold>i</bold>) (n=9) and of CLPX (<bold>j</bold> - <bold>k</bold>) (n=10) in synaptic and non-synaptic mitochondrial fractions. <bold>e, f, g, i</bold> and <bold>k</bold> show means ± S.E.M., determined by two-tailed Wilcoxon test (<bold>g</bold> and <bold>k</bold>) and two-tailed paired t-test (<bold>f</bold>, <bold>i</bold>), *<italic>P</italic> &lt; 0.05, <italic>**P</italic> &lt; 0.01.</p></caption><graphic xlink:href="EMS201563-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title>Synaptic mitochondria show higher Complex I integration in supercomplexes than non-synaptic mitochondria.</title><p>Immunodetection of Complex I subunits in BN-PAGE of digitonin-treated synaptic (S) and non-synaptic (NS) mitochondria fractions: NDUFS6 (<bold>a</bold>), NDUFV1 (<bold>b</bold>), NDUFV2 (<bold>c</bold>); NDUFB6 (<bold>d</bold>); and Complex II subunit SDHA (n=3) (<bold>e</bold>). Ratio quantification of Complex I integration in supercomplexes to individual Complex I of NDUFS6 (n=8) (<bold>f</bold>), NDUFV1 (n=7) (<bold>g</bold>), NDUFV2 (n=4) (<bold>h</bold>); NDUFB6 (n=5) (<bold>i</bold>). (<bold>j</bold>) Second-dimension BN/SDS-PAGE of digitonin-solubilized synaptic and non-synaptic mitochondria, followed by immunodetection of the NDUFV1 (Complex I) and UQCRFS1 (Complex III subunit). Ingel enzymatic activity of Complex I (<bold>k</bold>) and Complex IV (<bold>l</bold>) in digitonin-treated synaptic (S) and non-synaptic mitochondria (NS) (n=4). <bold>f-i</bold> show means ± S.E.M., determined by two-tailed paired t-test, *<italic>P &lt; 0.05, **P</italic> &lt; 0.01.</p></caption><graphic xlink:href="EMS201563-f005"/></fig><fig id="F6" position="float"><label>Fig. 6</label><caption><title>Synaptic mitochondria show differential arrangement of Complex V.</title><p>BN-PAGE (<bold>a</bold>) of digitonin-solubilized synaptic (S) and non-synaptic (NS) mitochondria fractions, using different digitonin:protein ratios (10:1 and 2:1) followed by immunodetection of Complex V subunit (ATP5B) (n=3). Ratio quantification of Complex V organization in oligomers to monomers (<bold>b</bold>) and dimers to monomers (<bold>c</bold>). <bold>b</bold> and <bold>c</bold> show means ± S.E.M., determined by two-tailed paired t-test, *<italic>P &lt; 0.05</italic>, **<italic>P &lt; 0.01</italic>.</p></caption><graphic xlink:href="EMS201563-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Primary Antibodies used in this study</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle">Antibody</th><th align="left" valign="middle">Source</th><th align="left" valign="middle">Catalogue number</th><th align="left" valign="middle">Dilution</th></tr></thead><tbody><tr><td align="left" valign="middle">Anti-PSD95</td><td align="left" valign="middle">Enzo Life Sciences</td><td align="left" valign="middle">ADI-VAM-PS002-E</td><td align="left" valign="middle">1:1,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-HSP60</td><td align="left" valign="middle">BD Biosciences</td><td align="left" valign="middle">611563</td><td align="left" valign="middle">1:5,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-Synaptophysin1</td><td align="left" valign="middle">Synaptic Systems</td><td align="left" valign="middle">101011</td><td align="left" valign="middle">1:1,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-Citrate Synthase</td><td align="left" valign="middle">Proteintech</td><td align="left" valign="middle">16131-1-AP</td><td align="left" valign="middle">1:2,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-SNAP25</td><td align="left" valign="middle">Sigma-Aldrich</td><td align="left" valign="middle">S9684</td><td align="left" valign="middle">1:5,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">anti-OXPHOS cocktail</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab110413</td><td align="left" valign="middle">1:2,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFS6</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab195807</td><td align="left" valign="middle">1:1,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFA10</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab19131</td><td align="left" valign="middle">1:500</td></tr><tr><td align="left" valign="middle">Anti-UQCRFS1</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab14746</td><td align="left" valign="middle">1:2,000<sup><xref ref-type="table-fn" rid="TFN1">a,b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-COXIV</td><td align="left" valign="middle">GeneTex</td><td align="left" valign="middle">ab33985</td><td align="left" valign="middle">1:1,000 <sup><xref ref-type="table-fn" rid="TFN1">a,b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFV1</td><td align="left" valign="middle">Novus Biologicals</td><td align="left" valign="middle">NBP1-33074</td><td align="left" valign="middle">1:500<sup><xref ref-type="table-fn" rid="TFN1">a,b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-ATPB</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab14730</td><td align="left" valign="middle">1:2,000<sup><xref ref-type="table-fn" rid="TFN1">b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFV2</td><td align="left" valign="middle">Proteintech</td><td align="left" valign="middle">15301-1-AP</td><td align="left" valign="middle">1:10,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFS1</td><td align="left" valign="middle">Proteintech</td><td align="left" valign="middle">12444-1-AP</td><td align="left" valign="middle">1:1,000<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-SDHA</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab14715</td><td align="left" valign="middle">1:10,000<sup><xref ref-type="table-fn" rid="TFN1">a,b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFB8</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab110242</td><td align="left" valign="middle">1:10,000 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFB6</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab110244</td><td align="left" valign="middle">1:10,000 <sup><xref ref-type="table-fn" rid="TFN1">a,b</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-CLPP</td><td align="left" valign="middle">Proteintech</td><td align="left" valign="middle">15698-1-AP</td><td align="left" valign="middle">1:500 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-CLPX</td><td align="left" valign="middle">Sigma-Aldrich</td><td align="left" valign="middle">HPA040262</td><td align="left" valign="middle">1:500 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-NDUFAF2</td><td align="left" valign="middle">Proteintech</td><td align="left" valign="middle">13891-1-AP</td><td align="left" valign="middle">1:500 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-MFN1</td><td align="left" valign="middle">Abnov<sup>a</sup></td><td align="left" valign="middle">H00055669-M04</td><td align="left" valign="middle">1:1,000 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-VDAC1</td><td align="left" valign="middle">Abcam</td><td align="left" valign="middle">ab154856</td><td align="left" valign="middle">1:5,000 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-MICU1</td><td align="left" valign="middle">Sigma-Aldrich</td><td align="left" valign="middle">HPA037480</td><td align="left" valign="middle">1:500 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr><tr><td align="left" valign="middle">Anti-MCU</td><td align="left" valign="middle">Sigma-Aldrich</td><td align="left" valign="middle">HPA016480</td><td align="left" valign="middle">1:10,000 <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>a - used for SDS-PAGE; b - used for BN-PAGE</p></fn></table-wrap-foot></table-wrap></floats-group></article>